EDGAR Filing Documents for 0001193125-18-223696

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-18-223696

Filing Date

2018-07-23

Accepted

2018-07-23 16:08:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d532575ds3.htm	S-3	324652
2	EX-4.2	d532575dex42.htm	EX-4.2	295553
3	EX-4.3	d532575dex43.htm	EX-4.3	319931
4	EX-4.4	d532575dex44.htm	EX-4.4	46114
5	EX-4.5	d532575dex45.htm	EX-4.5	44518
6	EX-5.1	d532575dex51.htm	EX-5.1	34186
7	EX-5.2	d532575dex52.htm	EX-5.2	7303
8	EX-23.1	d532575dex231.htm	EX-23.1	1587
9	EX-23.2	d532575dex232.htm	EX-23.2	2073
10	GRAPHIC	g532575g0719075128192.jpg	GRAPHIC	3563
11	GRAPHIC	g532575g36l34.jpg	GRAPHIC	2414
12	GRAPHIC	g532575g37a87.jpg	GRAPHIC	2737
	Complete submission text file	0001193125-18-223696.txt		1089467

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612

Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090

Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)